Universitätsklinikum Essen

Impact of bleeding and thrombosis on outcome of 945 COVID-19 VV-ECMO cases from a German registry (2025) Herrmann J, Schade J, Meybohm P, Paschke N, Hübsch ME, Notz Q, Groene J, et al. Journal article Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma. (2025) Wolchok JD, Chiarion-Sileni V, Rutkowski P, Cowey CL, Schadendorf D, Wagstaff J, Queirolo P, et al. Journal article Was sind Wundbeläge? Ein Positionspapier der Initiative Chronische Wunden (ICW) e. V. (2025) Dissemond J, Erfurt-Berge C, Gerber V, Motzkus M, Teubner K, Rembe JD Journal article Targeted Proteomics upon Treatment with Tofersen Identifies Novel Response Markers for Superoxide Dismutase 1-Linked Amyotrophic Lateral Sclerosis (2025) Steffke C, Baskar K, Bachhuber F, Wiesenfarth M, Dorst J, Schuster J, Schöberl F, et al. Journal article [68Ga]Ga-FAPI-46 PET accuracy for cancer imaging with histopathology validation: a single-centre, single-arm, interventional, phase 2 trial (2025) Pabst KM, Weber MM, Laschinsky C, Sandach P, Bartel T, Küper AT, Kessler L, et al. Journal article Gemtuzumab ozogamicin in first-line treatment of CBF-AML: insights from a retrospective multi-center analysis (2025) Ronnacker J, Muller PJ, Mikesch JH, Zukunft S, Weinbergerová B, Šrámek J, Valka J, et al. Journal article Guideline-recommended basic parameter adherence in neurocritical care stroke patients: Observational multicenter individual participant data analysis. (2025) Mrochen A, Alhaj Omar O, Pelz JO, Michalski D, Neugebauer H, Lehrieder D, Knier B, et al. Journal article Physical activity and exercise performance in patients after kidney transplantation – Data from the prospective KTx360° aftercare program (2025) Pape L, Boeck HT, Boyen J, Nöhre M, Schiffer L, Kück M, Schieffer E, et al. Journal article Long-term follow-up of real-world adjuvant anti-PD1 checkpoint inhibition and targeted therapy in stage III melanoma patients (2025) Lodde GC, Hassel JC, von Wasielewski I, Meier F, Mohr P, Kähler K, Hauschild A, et al. Journal article VINCENT: A randomized-controlled trial evaluating venetoclax plus azacitidine versus intensive chemotherapy in patients with newly diagnosed, NPM1-mutated AML (2025) Kretschmer L, Ruhnke L, Schliemann C, Fransecky L, Steffen B, Kaufmann M, Burchert A, et al. Journal article